These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2160797)

  • 21. Activation of the virion-associated RNA polymerase of vesicular stomatitis virus by melittin.
    Roy J; Chanda PK; Thornton GB; Luk D; Banerjee AK
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1265-71. PubMed ID: 6285902
    [No Abstract]   [Full Text] [Related]  

  • 22. pppA2'p5A' blocks vesicular stomatitis virus replication in intact cells.
    Alarcon B; Bugany H; Carrasco L
    J Virol; 1984 Oct; 52(1):183-7. PubMed ID: 6090695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA polymerase activity and poly(A) synthesizing activity in defective T particles of vesicular stomatitis virus.
    Reichmann ME; Villarreal LP; Kohne D; Lesnaw J; Holland JJ
    Virology; 1974 Mar; 58(1):240-9. PubMed ID: 4362548
    [No Abstract]   [Full Text] [Related]  

  • 24. Protamine--a potent inhibitor of vesicular stomatitis virus transcriptase in vitro.
    Talib S; Banerjee AK
    Biochem Biophys Res Commun; 1981 Feb; 98(3):875-83. PubMed ID: 6261754
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of 2'5'-oligoadenylic acid on a mouse cell line partially resistant to interferon.
    Panet A; Czarniecki CW; Falk H; Friedman RM
    Virology; 1981 Oct; 114(2):567-72. PubMed ID: 6170160
    [No Abstract]   [Full Text] [Related]  

  • 26. Reconstitution studies detect a single polymerase entry site on the vesicular stomatitis virus genome.
    Emerson SU
    Cell; 1982 Dec; 31(3 Pt 2):635-42. PubMed ID: 6297777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribonucleic acid polymerase induced in L-cells infected with vesicular stomatitis virus.
    Galet H; Shedlarski JG; Prevec L
    Can J Biochem; 1973 May; 51(5):721-9. PubMed ID: 4350448
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of interferon action III--significance of pppA2'p5'A2'p5'A in the antiviral action of interferon.
    Liu XY; Yao K; Zhou YX; Jin JR; Wen YM; Lou YC; Li BL; Wang DB
    Sci Sin B; 1983 Aug; 26(8):809-17. PubMed ID: 6194560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of serotype specificity in transcription of vesicular stomatitis virus synthetic nucleocapsids.
    Smallwood S; Richards-Sumners E; Moyer SA
    Virology; 1994 Feb; 199(1):11-9. PubMed ID: 8116233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of interferon and 2',5'-oligoadenylates on rotavirus RNA synthesis.
    Ríos M; Muñoz M; Torrence PF; Spencer E
    Antiviral Res; 1995 Mar; 26(2):133-43. PubMed ID: 7605112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleoside diphosphate kinase activity in purified cores of vesicular stomatitis virus.
    Testa D; Banerjee AK
    J Biol Chem; 1979 Sep; 254(18):9075-9. PubMed ID: 225322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.
    Jin Z; Tucker K; Lin X; Kao CC; Shaw K; Tan H; Symons J; Behera I; Rajwanshi VK; Dyatkina N; Wang G; Beigelman L; Deval J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7504-16. PubMed ID: 26392512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesicular stomatitis virus transcription inhibited by purified MxA protein.
    Schwemmle M; Weining KC; Richter MF; Schumacher B; Staeheli P
    Virology; 1995 Jan; 206(1):545-54. PubMed ID: 7831809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of vesicular stomatitis virus replication by poly(2'-fluoro-2'-deoxyuridylic acid).
    Grosch JC; Erickson RJ
    Antimicrob Agents Chemother; 1975 Nov; 8(5):544-50. PubMed ID: 174488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
    Bayard B; Bisbal C; Lebleu B
    Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased stability and antiviral activity of 2'-O-phosphoglyceryl derivatives of (2'-5')oligo(adenylate).
    Bayard B; Bisbal C; Silhol M; Cnockaert J; Huez G; Lebleu B
    Eur J Biochem; 1984 Jul; 142(2):291-8. PubMed ID: 6086347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
    Lemaitre M; Bayard B; Lebleu B
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):648-52. PubMed ID: 3027696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation.
    Grdzelishvili VZ; Smallwood S; Tower D; Hall RL; Hunt DM; Moyer SA
    Virology; 2006 Jul; 350(2):394-405. PubMed ID: 16537083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus.
    Chanda PK; Banerjee AK
    J Virol; 1981 Jul; 39(1):93-103. PubMed ID: 6268824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal by certain polyanions of an endogenous inhibitor of the vesicular stomatitis virus-associated transcriptase.
    Carroll AR; Wagner RR
    J Biol Chem; 1978 May; 253(10):3361-3. PubMed ID: 206538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.